Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06210685 · ClinicalTrials.gov registry record · NA
The ACES Study for Aseptic Pleural Effusion
A NA study of Pleural Effusion, sponsored by Pleural Dynamics.
- Active
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 4
- Study locations
NCT06210685: Active NA study of Pleural Effusion, sponsored by Pleural Dynamics.
NCT06210685 is a NA study of Pleural Effusion that is active but no longer recruiting, run by Pleural Dynamics. The registered enrollment target is 25 participants, below the 192-participant average among 6 other Pleural Effusion trials with a reported enrollment target (87% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06210685, a NA study of Pleural Effusion, is active but no longer recruiting, sponsored by Pleural Dynamics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 4
- Study locations
Study Summary
The study will enroll recurrent aseptic pleural effusion patients who are designated by their physician as needing treatment to control the fluid. Baseline assessment will include a history and physical, chest imaging and quality of life questionnaires. After ACES implantation, patients will remain under hospital care for general observation as per standard-of-care before being discharged home with access to electronic diaries for tracking pain and dyspnea.
Primary Outcome
Percentage change in pleural effusion volume via chest CT from baseline
Conditions Studied
Interventions
- DEVICE Automatic Continuous Effusion Shunt implantation
Study Locations (4)
Florida
- Memorial Healthcare System - Hollywood
Maryland
- Johns Hopkins School of Medicine - Baltimore
North Carolina
- University of North Carolina Pulmonary and Critical Care Medicine - Chapel Hill
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-05-12 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT06210685 still lists
NCT06210685 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 192-participant average among 6 other Pleural Effusion trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Pleural Effusion appearing as the primary indexed condition, and to 1 intervention - of which Automatic Continuous Effusion Shunt implantation is the first listed.
NCT06210685 reports a single indexed study location in Florida, Maryland, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06210685 about?
NCT06210685 is a clinical study titled "The ACES Study for Aseptic Pleural Effusion". The study will enroll recurrent aseptic pleural effusion patients who are designated by their physician as needing treatment to control the fluid. Baseline assessment will include a history and physical, chest imaging and quality of life questionnaires. After ACES implantation, patients will remain...
What is the current status of trial NCT06210685?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-05-12. Estimated completion is 2025-12.
What conditions does trial NCT06210685 study?
This clinical trial studies the following conditions: Pleural Effusion.
What interventions are being tested in trial NCT06210685?
The interventions under investigation include: Automatic Continuous Effusion Shunt implantation (DEVICE).
Who is sponsoring clinical trial NCT06210685?
This trial is sponsored by Pleural Dynamics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06210685 being conducted?
This trial has 4 study locations across Florida, Maryland, North Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pleural Effusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural Effusions
RECRUITING · NA
-
Gravity Versus Vacuum Based Indwelling Tunneled Pleural Drainage System
RECRUITING · NA
-
Impact of Pleural Manometry on Chest Discomfort After Therapeutic Thoracentesis
COMPLETED · NA
-
Drainage Amount for Removal of Thoracostomy Tube
COMPLETED · NA
-
Intrapleural Catheter Daily Versus Three Times a Week Drainage
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI